News
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Semaglutide may be prescribed for different reasons and some forms may be more suitable for you than others: Ozempic. Ozempic is approved by the FDA (U.S. Food and Drug Administration) for type 2 ...
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...
The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results